In a multicenter screening study for trisomy 21 involving ultrasonographic measurement of fetal nuchal translucency thickness (NT) at 10-14 weeks of gestation, 100,311 singleton pregnancies with a live fetus were examined. There were 46 cases of trisomy 13, and in 33 (72%) of these, the NT was above
Pathophysiology of increased nuchal translucency in chromosomally abnormal fetuses
โ Scribed by C. S. von Kaisenberg; K. H. Nicolaides; W. Jonat; B. Brand-Saberi
- Publisher
- Springer
- Year
- 1999
- Tongue
- German
- Weight
- 280 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0017-5994
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
At 10-14 weeks of gestation more than 80 per cent of fetuses affected by trisomy 21 can be detected by a screening programme based on a combination of maternal age and fetal nuchal translucency thickness (NT). The screen positive group in such a programme also identifies fetuses with sex chromosome
This study examines GATA-4 gene expression in cardiac tissue from fetuses with trisomy 21 presenting with increased nuchal translucency thickness at 10-14 weeks of gestation. mRNA was extracted from cardiac tissue after termination of pregnancy at 10-18 weeks of gestation in ten trisomy 21 fetuses a
Makrydimas and colleagues recently reported two cases of subcutaneous edema in the back of the fetal neck at 10-14 weeks associated with osteogenesis imperfecta [Makrydimas et al., 2001]. We report a very similar case we have observed at 13 and 16 weeks in a pregnancy without any family risk. A hea
Pathological examination of the heart and great arteries was performed in 112 chromosomally abnormal fetuses after surgical termination of pregnancy at 11-16 weeks of gestation. The chromosomal abnormalities were diagnosed by chorion villus sampling which was carried out because screening of the pre